Vital Signsby BridgeheadAll voices

01  Voice · Sector leader · Respiratory (asthma/COPD)

Kaivan Khavandi: no photograph is held, so the sector leader plate is shown instead.
Sector leader

Kaivan Khavandi

head of respiratory, immunology, and inflammation R&D at GSK

Press citations per month · linked articles
1
0
0
0
0
0
0
1
0
0
Feb 2026MarAprMayJuneJulyAugSeptOctNovto date
2

press citations on 1 topic since 17 Feb 2026 · last quoted 23 Sept 2026

02  Quoted on · 1 of 29 topics

Open the topic

Kaivan Khavandi: key facts

Kind of voice
Sector leader
Role
head of respiratory, immunology, and inflammation R&D at GSK
Tracked press citations
2
Most recently quoted
23 Sept 2026
First quoted
17 Feb 2026

04  The signal · where Kaivan Khavandi sits on respiratory (asthma/copd)

Ranked 18= of 100 voices quoted in the press on respiratory (asthma/copd), level with 32 others on 2 citations.

Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.

  1. 1=Darush Attar-ZadehClinicianExecutive Chair, Primary Care Respiratory Society; Clinical Fellow Respiratory Pharmacist, North West London Integrated Care Board, Primary Care Respiratory Society (PCRS)7
  2. 1=Dr Andy Whittamore portraitDr Andy WhittamoreClinicianClinical Lead (and practising GP), Asthma + Lung UK7
  3. 3Alvar Agusti, MD, PhD portraitAlvar Agusti, MD, PhDAcademicProfessor of Medicine; Chair, GOLD Board of Directors, University of Barcelona / Hospital Clínic de Barcelona5
  4. 18=Dr Abhishek ShankarAcademicauthor of a perspective on lung cancer screening published by the IARC2
  5. 18=Dr. Meilan HanAcademicchief of the division of pulmonary and critical care at the University of Michigan Health and one of the investigators of the study2
  6. 18=Kaivan KhavandiSector leaderhead of respiratory, immunology, and inflammation R&D at GSK2
  7. 18=Dr Charlotte RandallClinicianConsultant forensic pathologist2
  8. 18=Dr Divya KathikeyanAcademicgeneral practitioner at TelDoc2

Showing the leaders and the ranks around 18=, of 100 voices · See every voice on the topic →

05  On the record · press

What Kaivan Khavandi has said

By outlet · linked articles
  • es.tradingview.com1
  • pharmaphorum.com1

Where Kaivan Khavandi has been quoted

  1. 01GSK Bets on Long-Acting Biologics and AI to Reshape Respiratory Carees.tradingview.com · 23 Sept 2026
  2. 02EU approval for new asthma drug Exdensur lifts GSKpharmaphorum.com · 17 Feb 2026

Verbatim

“GSK is advancing a respiratory and immunology pipeline centered on longer-acting biologics, more targeted patient selection and combination approaches”
Senior Vice President and Global Head of Translational and Development Sciences at GSK · Respiratory (asthma/COPD) · es.tradingview.com · 23 Sept 2026 · Read the article
“redefine care for the millions of patients living with these persistent and burdensome conditions, supporting them in achieving their treatment goals with just two doses a year.”
head of respiratory, immunology, and inflammation R&D at GSK · Respiratory (asthma/COPD) · pharmaphorum.com · 17 Feb 2026 · Read the article

Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.